25-Hydroxyvitamin D3 1-alpha-Hydroxylase
                                 
                                
                                
                                    
                                
                                
                                    
                                
                                
                                
                                    
                                        
                                                
    "25-Hydroxyvitamin D3 1-alpha-Hydroxylase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
    
    
        
            
            
                A mitochondrial cytochrome P450 enzyme that catalyzes the 1-alpha-hydroxylation of 25-hydroxyvitamin D3 (also known as 25-hydroxycholecalciferol) in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP27B1 gene, converts 25-hydroxyvitamin D3 to 1-alpha,25-dihydroxyvitamin D3 which is the active form of VITAMIN D in regulating bone growth and calcium metabolism. This enzyme is also active on plant 25-hydroxyvitamin D2 (ergocalciferol).
    
            
            
                
                    
                        
                            | Descriptor ID | D015090 | 
                        
                            | MeSH Number(s) | D08.244.453.499.500 D08.244.453.915.400 D08.811.682.690.708.170.493.500 D08.811.682.690.708.170.915.400 D12.776.422.220.453.499.500 D12.776.422.220.453.915.400 | 
                        
                            | Concept/Terms | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase25-Hydroxyvitamin D3 1-alpha-Hydroxylase25 Hydroxyvitamin D3 1 alpha Hydroxylase25-Hydroxycholecalciferol 1-HydroxylaseCalcidiol 1-MonooxygenaseCalcidiol 1 Monooxygenase25-Hydroxyvitamin D(3) 1 alpha-Hydroxylase25-Hydroxyvitamin D 1-alpha-Hydroxylase1-alpha-Hydroxylase, 25-Hydroxyvitamin D25 Hydroxyvitamin D 1 alpha HydroxylaseCYP27B1Cytochrome P-450 CYP27B1Cytochrome P 450 CYP27B125-Hydroxyergocalciferol 1-alpha-Hydroxylase1-alpha-Hydroxylase, 25-Hydroxyergocalciferol25 Hydroxyergocalciferol 1 alpha Hydroxylase25-Hydroxycholecalciferol-1-Hydroxylase25 Hydroxycholecalciferol 1 Hydroxylase25-Hydroxyvitamin D2 1-hydroxylase1-hydroxylase, 25-Hydroxyvitamin D225 Hydroxyvitamin D2 1 hydroxylase
 | 
                    
                
             
            
                Below are MeSH descriptors whose meaning is more general than "25-Hydroxyvitamin D3 1-alpha-Hydroxylase".
                
             
            
            
                Below are MeSH descriptors whose meaning is more specific than "25-Hydroxyvitamin D3 1-alpha-Hydroxylase".
                
             
         
     
 
                                            
                                                
	
	
		
			
			
					
				This graph shows the total number of publications written about "25-Hydroxyvitamin D3 1-alpha-Hydroxylase" by people in this website by year, and whether "25-Hydroxyvitamin D3 1-alpha-Hydroxylase" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2003 | 0 | 1 | 1 | 
| 2013 | 1 | 0 | 1 | 
| 2016 | 1 | 0 | 1 | 
| 2017 | 1 | 3 | 4 | 
| 2018 | 0 | 3 | 3 | 
| 2019 | 1 | 0 | 1 | 
                   To return to the timeline, click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "25-Hydroxyvitamin D3 1-alpha-Hydroxylase" by people in Profiles.
						
					
								- 
								Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients. BMC Infect Dis. 2021 Jun 19; 21(1):588. 
- 
								Vitamin D enzymes (CYP27A1, CYP27B1, and CYP24A1) and receptor expression in non-melanoma skin cancer. Acta Biochim Biophys Sin (Shanghai). 2019 Apr 01; 51(4):444-447. 
- 
								Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. Infect Genet Evol. 2018 06; 60:42-47. 
- 
								Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. Cancer Chemother Pharmacol. 2018 03; 81(3):615-620. 
- 
								Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children. Pharmacogenet Genomics. 2018 Jan; 28(1):17-22. 
- 
								Role of Vitamin D in Maintaining Renal Epithelial Barrier Function in Uremic Conditions. Int J Mol Sci. 2017 Nov 26; 18(12). 
- 
								Endogenous Calcitriol Synthesis Controls the Humoral IgE Response in Mice. J Immunol. 2017 12 15; 199(12):3952-3958. 
- 
								Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord. 2017 09; 18(3):335-346. 
- 
								Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC Gastroenterol. 2017 Apr 17; 17(1):54. 
- 
								Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cells. Oncotarget. 2016 Jun 14; 7(24):35512-35521.